Efficacy and safety of antifungal prophylaxis in surgical intensive care unit patients: A systematic review and meta-analysis of randomized controlled trials. [PDF]
Kadariswantiningsih IN +8 more
europepmc +1 more source
At What Cost Echinocandin Resistance? [PDF]
Cornelius J, Clancy, M Hong, Nguyen
openaire +2 more sources
Triazoles Versus Echinocandins for the First-Line Treatment of Invasive Pulmonary Aspergillosis: A Propensity Score-Weighted Multicenter Study. [PDF]
Hatzl S +9 more
europepmc +1 more source
Neonatal Candidemia in Latin America: Trends, Resistance, and Prevention Strategies (2008-2025). [PDF]
Soto Guzmán FG +2 more
europepmc +1 more source
SCY-247, a novel second-generation triterpenoid antifungal, demonstrates high in vitro activity against genetically diverse Candida auris isolates, including FKS1 mutants. [PDF]
Spruijtenburg B, de Groot T, Meijer EFJ.
europepmc +1 more source
Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real-World Clinical Practice. [PDF]
Boán J +10 more
europepmc +1 more source
Evaluation of the Synergistic Activity of Anidulafungin with Isavuconazole, Voriconazole, Posaconazole, and Amphotericin B in <i>Candida auris</i> (<i>Candidozyma auris</i>) Isolates. [PDF]
Turan D, Sarmis A, Adaleti R, Aksaray S.
europepmc +1 more source
Echinocandins: Resistance Mechanisms [PDF]
Santosh Katiyar, Thomas Edlind
openaire +1 more source
Rezafungin in fluconazole-resistant and refractory candidiasis: the first Brazilian experience. [PDF]
Kruschewsky WLL +7 more
europepmc +1 more source
Diagnosis and management of invasive candidiasis in critically ill patients: SIAARTI multidisciplinary statement. [PDF]
Cortegiani A +13 more
europepmc +1 more source

